Genalyte Inc:製品パイプライン分析

GlobalDataが発行した調査報告書(DATA8010534)
◆英語タイトル:Genalyte Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010534
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年12月6日
◆ページ数:31
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the binding of biomolecules to silicon photonic biosensors. Genalyte uses a silicon chip containing arrays of photonic ring sensors to reduce sample preparation and offer scalable multiplexing for both proteins and nucleic acids. The company’s technology is used by pharmaceutical companies and academic researchers to screen for cancer biomarkers, monitor autoimmune diseases, detect anti-drug antibodies, and to test for infectious agents such as Ebola, among others. Its biosensors can be lithographically printed on a single disposable silicon chip making multi-analyte panels of tests possible. Genalyte is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Genalyte Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Genalyte Inc Company Overview 4
Genalyte Inc Company Snapshot 4
Genalyte Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Genalyte Inc – Pipeline Analysis Overview 7
Genalyte Inc – Key Facts 7
Genalyte Inc – Major Products and Services 8
Genalyte Inc Pipeline Products by Development Stage 9
Genalyte Inc Pipeline Products Overview 11
Diagnostic Assay – Ebola Virus 11
Diagnostic Assay – Ebola Virus Product Overview 11
Maverick ANA 11 Assay Kit 12
Maverick ANA 11 Assay Kit Product Overview 12
Maverick Detection System 13
Maverick Detection System Product Overview 13
Maverick Rheumatoid Arthritis Multiplex Assay Kit 14
Maverick Rheumatoid Arthritis Multiplex Assay Kit Product Overview 14
Maverick Type 1 Diabetes (T1D) Assay Kit 15
Maverick Type 1 Diabetes (T1D) Assay Kit Product Overview 15
Tumor Antigen-Associated Biomarker Panel 16
Tumor Antigen-Associated Biomarker Panel Product Overview 16
Genalyte Inc – Key Competitors 17
Genalyte Inc – Key Employees 18
Genalyte Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Genalyte Inc, Recent Developments 20
Nov 12, 2016: New Clinical Study Demonstrates Feasibility of Performing Multiplex ANA Testing on Whole Blood via Finger-Stick in Physician Office Near-Patient Setting 20
Nov 07, 2016: First-Ever Clinical Results for Rapid, Near-Patient Diagnostics Platform to Be Presented At ACR/ARHP Annual Meeting 20
Jun 15, 2016: Genalyte Appoints William A. Hagstrom to Board of Directors 21
Feb 03, 2015: Genalyte, Collaborators Gear Up for Phase Two of Tumor-associated Antigen Panel Development 21
Feb 03, 2015: Genalyte, Collaborators Gear Up for Phase Two of Tumor-associated Antigen Panel Development 22
Feb 02, 2015: Biotech Firm Genalyte Announces Hiring of Former Defense Department Advisor Todd Ritter 23
Jan 28, 2015: Genalyte Completes First Phase of National Cancer Institute Grant Program 24
Oct 22, 2014: Genalyte Finger Prick Test Can Rapidly & Affordably Detect Ebola Virus at Early Stage 25
Oct 18, 2013: Genalyte Expands Into Cancer Profiling With $1 Million NCI Grant To Develop Cancer Biomarker Panel; Establishes Collaborations With Three Cancer Research Centers 25
Aug 15, 2013: Genalyte And Barbara Davis Diabetes Center Collaborate To Advance Multiplexed Antigen Panel For Early Diagnosis Of Type 1 Diabetes 26
Appendix 28
Methodology 28
About GlobalData 30
Contact Us 30
Disclaimer 31

List of Tables
Genalyte Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Genalyte Inc Pipeline Products by Equipment Type 5
Genalyte Inc Pipeline Products by Indication 6
Genalyte Inc, Key Facts 7
Genalyte Inc, Major Products and Services 8
Genalyte Inc Number of Pipeline Products by Development Stage 9
Genalyte Inc Pipeline Products Summary by Development Stage 10
Diagnostic Assay - Ebola Virus - Product Status 11
Diagnostic Assay - Ebola Virus - Product Description 11
Maverick ANA 11 Assay Kit - Product Status 12
Maverick ANA 11 Assay Kit - Product Description 12
Maverick Detection System - Product Status 13
Maverick Detection System - Product Description 13
Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Status 14
Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Description 14
Maverick Type 1 Diabetes (T1D) Assay Kit - Product Status 15
Maverick Type 1 Diabetes (T1D) Assay Kit - Product Description 15
Tumor Antigen-Associated Biomarker Panel - Product Status 16
Tumor Antigen-Associated Biomarker Panel - Product Description 16
Genalyte Inc, Key Employees 18
Glossary 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Genalyte Inc:製品パイプライン分析(Genalyte Inc - Product Pipeline Analysis, 2017 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆